Combination therapy involving three drugs – elexacaftor, tezacaftor, and ivacaftor (IMAGE)

Charité - Universitätsmedizin Berlin

Combination therapy involving three drugs – elexacaftor, tezacaftor, and ivacaftor

Caption

Combination therapy involving three drugs – elexacaftor, tezacaftor, and ivacaftor – makes the mucus in the airways of cystic fibrosis patients (shown in green in the figure above) less thick and sticky. This makes it easier for the lungs to clear bacteria, and there are fewer respiratory inflammation cells.

Credit

Charité | Laura Schaupp

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.